Search
for
Sort by
Research 91–120 of 1000+
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study
- 307 Phenotypic-genotypic expansion of plectinopathy in a patient with muscular dystrophy and immune-mediated myasthenia gravis
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- [Hypothyroid myopathy in a young adult].
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- 494 Epidermolysis bullosa pruriginosa, muscular dystrophy, and immune-mediated myasthenia gravis in a patient with homozygous nonsense PLEC mutation
- Secretory phospholipase A2-IIA overexpressing mice exhibit cyclic alopecia mediated through aberrant hair shaft differentiation and impaired wound healing response
- The atypical ‘hippocampal’ glutamate receptor coupled to phospholipase D that controls stretch‐sensitivity in primary mechanosensory nerve endings is homomeric purely metabotropic GluK2
- A network pharmacology-based approach to explore mechanism of action of medicinal herbs for alopecia treatment
- Resequencing Analyses Revealed Genetic Diversity and Selection Signatures during Rabbit Breeding and Improvement
- Targeted Inactivation of Gh/Tissue Transglutaminase II
- Hair Follicle Signaling Networks: A Dermal Papilla–Centric Approach
- Fundus changes in systemic lupus erythematosus
- Clinical Profile and Outcomes of Patients With Systemic Lupus Erythematosus
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Neuroimaging Findings in Congenital Biotinidase Deficiency: A Case Report
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- A 25-year-old female with a variable presentation of MCTD-A case report
- A Case of Hemi‐Isaac's Syndrome
- Comprehensive analysis of differences in cashmere production performance in Liaoning cashmere goats by using metabolomics and transcriptomics
- Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract
- LncRNA-miRNA-mRNA regulatory networks in skin aging and therapeutic potentials
- Hoxc13 polyglycine repeat gain-of-function drives mammalian integument evolution by altering targeted genes and interactions
- Integrative Whole-Transcriptome Sequencing Analysis of Skin Tissues with Different Coat Types in Cashmere Goats Across Stages of Hair Follicle Development
- LncRNAs regulate the cyclic growth and development of hair follicles in Dorper sheep
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Lipid nanocarriers as innovative strategies for hair regrowth
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications